Period Ending | Dec 31, 2009 | Dec 31, 2008 |
---|
Total Revenue
|
5,233,000
|
4,204,000
| Cost of Revenue | 3,327,000 | 2,428,000 | |
Gross Profit
|
1,906,000
|
1,776,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
|
Selling General and Administrative | 365,000 | 361,000 |
|
Non Recurring |
-
|
-
|
|
Others |
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
| | |
Operating Income or Loss
|
1,541,000
|
1,415,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 5,000 | 19,000 |
|
Earnings Before Interest And Taxes | 1,546,000 | 1,434,000 |
|
Interest Expense | 27,000 |
-
|
|
Income Before Tax | 1,519,000 | 1,434,000 |
|
Income Tax Expense | 571,000 | 547,000 |
|
Minority Interest |
-
|
-
|
|
|
|
Net Income From Continuing Ops | 948,000 | 887,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | |
Net Income
|
948,000
|
887,000
| Preferred Stock And Other Adjustments |
-
|
-
| |
Net Income Applicable To Common Shares
|
$948,000
|
$887,000
|
|